Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 EUR | -2.38% | +1.23% | +4.13% |
20/05 | Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096 | CI |
06/03 | Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- HRTIS Stock
- News Herantis Pharma Oyj
- Analyst Reco.